Plain-English translation of NCT07775846 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This study is testing whether a combination of four medications—including , , and , all taken alongside a standard blood pressure medication—can better protect your kidneys if you have type 2 diabetes and early signs of kidney damage. Researchers want to see if using more medications together works better than using fewer. You'll be randomly assigned to receive different combinations of these treatments to compare which approach slows kidney damage most effectively.
Type 2 diabetes can gradually damage the kidneys over time, leading to serious complications. Current treatments help, but they don't always stop the damage. This trial is testing whether combining several protective medications together might work better than current standard approaches.
You likely qualify if…
You likely don't qualify if…
You will visit the study site multiple times over about 6 months. At each visit, you'll have blood and urine tests to monitor your kidney function and blood sugar. You'll take your assigned combination of medications daily at home—some participants will receive all four active medications, while others will receive two or three active medications plus placebo pills (inactive pills that look real). The study team will track how well the different medication combinations work at slowing kidney damage and check for any side effects.
AI-generated summary from trial data · Nov 11, 2026 · Not medical advice
China